DJ Biogen Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Biogen Inc. $(BIIB)$ inched 0.37% higher to $156.00 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index remaining mostly unchanged at 5,917.11 and the Dow Jones Industrial Average rising 0.32% to 43,408.47.
The stock's rise snapped a 10-day losing streak.
Biogen Inc. closed $112.30 below its 52-week high ($268.30), which the company achieved on January 3rd.
The stock outperformed some of its competitors Wednesday, as Johnson & Johnson $(JNJ)$ rose 0.07% to $153.11 and Pfizer Inc. $(PFE)$ fell 0.64% to $24.94.
Trading volume (1.6 M) eclipsed its 50-day average volume of 1.4 M.
Data source: Dow Jones Market Data, FactSet. Data compiled November 20, 2024.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
November 20, 2024 17:07 ET (22:07 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Comments